{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T07:19:22Z","timestamp":1720509562286},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1093\/humrep\/dex368","type":"journal-article","created":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T20:14:26Z","timestamp":1512418466000},"page":"303-310","source":"Crossref","is-referenced-by-count":9,"title":["Aromatase inhibitor use during ovarian stimulation suppresses growth of uterine endometrial cancer in xenograft mouse model"],"prefix":"10.1093","volume":"33","author":[{"given":"Tai","family":"Kawahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seido","family":"Takae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Uekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Kashiwazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yodo","family":"Sugishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"key":"key\n\t\t\t\t20180122095143_dex368C1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.fertnstert.2006.12.068","article-title":"Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma","volume":"88","year":"2007","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180122095143_dex368C2","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/jog.12442","article-title":"Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics","volume":"40","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"key\n\t\t\t\t20180122095143_dex368C3","first-page":"5417","article-title":"Photoaffinity labeling of the progesterone receptor from human endometrial carcinoma","volume":"45","year":"1985","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180122095143_dex368C4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","article-title":"Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials","volume":"386","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180122095143_dex368C5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM196102022640503","article-title":"Progestational agents in the treatment of carcinoma of the endometrium","volume":"264","year":"1961","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180122095143_dex368C7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.fertnstert.2012.06.015","article-title":"Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?","volume":"98","year":"2012","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180122095143_dex368C8","first-page":"650","article-title":"The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers\u2014a study of the National Cancer Institute of Canada Clinical Trials Group","volume":"4","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"key\n\t\t\t\t20180122095143_dex368C9","first-page":"109","article-title":"Establishment of eighteen clones of Ishikawa cells","volume":"9","year":"1996","journal-title":"Hum Cell"},{"key":"key\n\t\t\t\t20180122095143_dex368C11","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","year":"2005","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180122095143_dex368C12","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1200\/JCO.2014.59.3723","article-title":"Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer","volume":"33","year":"2015","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180122095143_dex368C14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.fertnstert.2012.09.022","article-title":"Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer","volume":"98","year":"2012","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180122095143_dex368C15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/humrep\/dex027","article-title":"The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review","volume":"32","year":"2017","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180122095143_dex368C16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/gyno.2000.5865","article-title":"A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study","volume":"78","year":"2000","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20180122095143_dex368C17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0090-8258(74)90024-9","article-title":"The role of radical hysterectomy in adenocarcinoma of the endometrium","volume":"2","year":"1974","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20180122095143_dex368C18","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180122095143_dex368C19","first-page":"5","article-title":"Cancer statistics","volume":"65","year":"2015","journal-title":"CA Cancer J Clin 2015"},{"key":"key\n\t\t\t\t20180122095143_dex368C20","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1245\/s10434-009-0736-6","article-title":"Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study","volume":"16","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"key\n\t\t\t\t20180122095143_dex368C21","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjc.6605086","article-title":"Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort","volume":"100","year":"2009","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t20180122095143_dex368C22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.gore.2017.05.003","article-title":"Successful treatment of low-grade endometrial cancer in premenopausal women with an aromatase inhibitor after failure with oral or intrauterine progesterone","volume":"21","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"key\n\t\t\t\t20180122095143_dex368C24","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1158\/1078-0432.CCR-09-1013","article-title":"Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions","volume":"15","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20180122095143_dex368C25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ygyno.2013.09.023","article-title":"Neoadjuvant treatment of endometrial cancer using anastrozole: a randomised pilot study","volume":"131","year":"2013","journal-title":"Gynecol Oncol"},{"key":"key\n\t\t\t\t20180122095143_dex368C27","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate","volume":"85","year":"2006","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180122095143_dex368C28","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","year":"2007","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180122095143_dex368C29","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/OGX.0b013e31821285bf","article-title":"Safety of pregnancy after primary breast carcinoma in young women: a meta-analysis to overcome bias of healthy mother effect studies","volume":"65","year":"2010","journal-title":"Obstet Gynecol Surv"},{"key":"key\n\t\t\t\t20180122095143_dex368C30","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(99)05203-4","article-title":"Risk of cancer after use of fertility drugs with in-vitro fertilisation","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180122095143_dex368C31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/me.2005-0280","article-title":"The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17\u03b2-estradiol and hydroxytamoxifen in endometrial cancer cells","volume":"20","year":"2006","journal-title":"Mol Endocrinol"},{"key":"key\n\t\t\t\t20180122095143_dex368C32","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","article-title":"Risk of endometrial cancer following estrogen replacement with and without progestins","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/33\/2\/303\/23602362\/dex368.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T14:53:51Z","timestamp":1516632831000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/33\/2\/303\/4781342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,28]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,12,28]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dex368","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,12,28]]}}}